Antidote uses precision recruitment to match the right patients with the right trials, striking the right balance between technology and human touch to deliver high-quality patient engagement. This is achieved through the integration of data-driven technologies, digital expertise, deep domain experience, an extensive diverse partner network, and personalized patient and site services.

In the first quarter of 2021 alone, the company surpassed its entire 2020 revenue. Funding is allowing the company to build on its commercial success and accelerate growth. The company is enhancing its clinical trial search engine, launching new products and services, and expanding its footprint internationally. The current CEO has over 30 years of experience in pharmaceuticals, so is well placed to continue this rapid growth over the coming years.